A

AIM Vaccine Co Ltd
HKEX:6660

Watchlist Manager
AIM Vaccine Co Ltd
HKEX:6660
Watchlist
Price: 1.76 HKD -7.37%
Market Cap: HK$2.2B

Intrinsic Value

The intrinsic value for AIM Vaccine Co Ltd (6660) under the Base Case is 1.22 HKD. Compared with the current market price of 1.76 HKD, the stock appears Overvalued by 31% .

Intrinsic value calculated using DCF
HK$1.22
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
HK$1.22
Overvaluation 31%
Intrinsic Value
Price HK$1.76
A
Monitor AIM Vaccine Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value HK$0.98
Get notified when the price drops into your buy zone
Current Price HK$1.76
Intrinsic Value HK$1.22
Margin of Safety 20% HK$0.98
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about AIM Vaccine Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AIM Vaccine Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for AIM Vaccine Co Ltd.

Explain Valuation
Alternatives to AIM Vaccine Co Ltd

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
AIM Vaccine Co Ltd

Efficiency

Earnings Waterfall
AIM Vaccine Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one AIM Vaccine Co Ltd stock?

The intrinsic value for AIM Vaccine Co Ltd (6660) under the Base Case is 1.22 HKD.

Is AIM Vaccine Co Ltd stock undervalued or overvalued?

Compared with the current market price of 1.76 HKD, the stock appears Overvalued by 31% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett